Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IDEV vs. HFXI: which is better?

Bottom line

IDEV vs HFXI: the short answer

IDEV (iShares Core MSCI International Developed Markets ETF) and HFXI (NYLI FTSE International Equity Currency Neutral ETF) share a meaningful slice of their top holdings — about 72% by weight.

But IDEV is far broader, holding 2,337 positions to 930 for HFXI, so beyond the top names it adds exposure HFXI doesn't have.

IDEV is cheaper at 0.04% vs 0.2% — a difference of $16 a year per $10,000 invested.

Over five years, HFXI returned +11.2% a year vs +5.0% for IDEV (reporting dates differ).

Updated Nov 19, 2026

IDEV vs HFXI side by side

IDEVHFXI
TypeETFETF
Fund familyiSharesNew York Life Investments
CategoryInternational StockInternational Stock
Expense ratio0.04%0.2%
Annual cost per $10k$4$20
10-yr cost on $10k (prospectus)$51$255
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+4.5%+30.1%
5-yr return (annualized)+5.0%+11.2%
10-yr return (annualized)—+9.5%
Best quarter+16.9%+15.0%
Worst quarter−24.0%−21.3%
Net assets (fund)$31.6B$2.0B
Number of holdings2,337930
Portfolio turnover3%14%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIDEVHFXIDifference
2024+4.5%+7.6%−3.1%
2023+17.3%+19.5%−2.2%
2022−14.9%−10.6%−4.3%
2021+12.7%+13.9%−1.2%
2020+8.4%+7.2%+1.2%
2019+23.4%+22.9%+0.5%
2018−14.3%−12.0%−2.4%

Source: Fund prospectus bar charts

Holdings overlap

16 of IDEV's top 25 holdings also appear in HFXI's top 25.

Shared top holdings
HoldingIDEVHFXI
ASML Holding N.V.2.19%2.43%
Hsbc Holdings Plc1.24%1.38%
Roche Holding AG1.05%1.22%
Novartis AG0.98%1.12%
Astrazeneca Plc0.88%0.97%
Shell Plc0.88%0.98%
Mitsubishi UFJ Financial Group, Inc.0.82%0.96%
Commonwealth Bank Of Australia0.72%0.81%
Banco Santander, S.A.0.70%0.78%
Sap Se0.65%0.72%
Allianz SE0.65%0.75%
Schneider Electric Se0.63%0.71%
Totalenergies Se0.59%0.67%
UBS Group AG0.57%0.64%
Rolls-royce Holdings Plc0.57%0.64%

Source: SEC Form N-PORT

IDEV top 10

  1. ASML Holding N.V. — 2.19%
  2. Hsbc Holdings Plc — 1.24%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
  4. Roche Holding AG — 1.05%
  5. Royal Bank Of Canada — 1.00%
  6. Novartis AG — 0.98%
  7. Astrazeneca Plc — 0.88%
  8. Nestle S.A. — 0.88%
  9. Shell Plc — 0.88%
  10. Siemens Aktiengesellschaft — 0.83%

HFXI top 10

  1. Samsung Electronics Co Ltd — 3.70%
  2. Sk Hynix Inc — 2.61%
  3. Asml Holding Nv — 2.43%
  4. Hsbc Holdings Plc — 1.38%
  5. Roche Holding Ag — 1.22%
  6. Novartis Ag — 1.12%
  7. Shell Plc — 0.98%
  8. Nestle' Sa/ag — 0.98%
  9. Astrazeneca Plc — 0.97%
  10. Mitsubishi Ufj Financial Group Inc — 0.96%

FAQ

What is the difference between IDEV and HFXI?
IDEV (iShares Core MSCI International Developed Markets ETF) and HFXI (NYLI FTSE International Equity Currency Neutral ETF) share a meaningful slice of their top holdings — about 72% by weight. But IDEV is far broader, holding 2,337 positions to 930 for HFXI, so beyond the top names it adds exposure HFXI doesn't have.
Which is cheaper, IDEV or HFXI?
IDEV has the lower expense ratio (0.04%).
Should I own both IDEV and HFXI?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.